rfhg_173373.1

Basic information about the TSS

---

TSS ID: rfhg_173373.1 Species: human Chr: chr15		Start: 44537079 End: 44537079 Strand: +
Source datasets	PRJNA597322
Protocol	STRIPE-seq
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2783050,EH38E1758340)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK023388:40 GeneID: 8669 HGNC/MGI_ID: HGNC:3270 UniProt_ID: Nearer transcript ids and distances:

Gene_name: EIF3J Gene_symbol: EIF3J Gene_synonyms: eIF3-alpha eIF3-p35 Gene_source: HGNC:3270

TATA-Box annotation

---

Distance to TSS:	11
Nearest PromoterID:	NM_001284336
Entrez ID:	8669
Nearest Unigene:	Hs.404056
Nearest Refseq:	NM_003758
Nearest Ensembl:	ENSG00000104131
Gene Name:	EIF3J
Gene Alias:	EIF3S1|eIF3-alpha|eIF3-p35
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EIF3J p2@EIF3J
Sample		p1@EIF3J	p2@EIF3J
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	196.95	30.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	194.23	27.31
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	225.31	31.06
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	204.58	27.03
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	229.92	31.27
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	233.35	34.89
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	292.84	49.68
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	277.34	37.30
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	233.38	31.42
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	279.96	35.36
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	253.86	33.15
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	278.49	37.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	65.28	14.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	55.18	15.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	59.28	13.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	57.09	11.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	53.07	12.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	54.84	11.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	81.04	23.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	69.05	18.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	64.15	14.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	81.13	17.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	60.75	13.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	67.22	15.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	84.62	14.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	85.46	18.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	85.72	25.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	91.47	20.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	86.74	18.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	83.43	15.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	73.90	15.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	72.68	20.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	85.26	17.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	96.49	20.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	76.67	15.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	79.72	14.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	75.42	15.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	64.88	12.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	78.87	14.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	82.10	15.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	74.34	12.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	88.86	16.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	72.76	19.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	76.22	15.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	81.71	16.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	82.82	14.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	71.97	17.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	82.56	21.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	75.40	15.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	84.32	18.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	64.56	15.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	59.15	17.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1539.14	237.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	44.36	10.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	44.07	11.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	187.92	32.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	103.79	19.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	41.16	10.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	31.15	8.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	83.30	11.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	48.65	13.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	40.38	12.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	179.13	14.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	82.22	11.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	40.29	10.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	31.95	10.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1664.89	274.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1279.39	229.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	46.80	9.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	61.98	15.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	45.97	7.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	70.54	7.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	41.14	12.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	44.33	14.06
Adipocyte - breast, donor1	11376-118A8	60.82	34.84
Adipocyte - breast, donor2	11327-117E4	56.31	33.69
Adipocyte - omental, donor1	11473-119C6	90.08	48.22
Adipocyte - omental, donor2	11474-119C7	53.82	19.43
Adipocyte - omental, donor3	11475-119C8	69.66	23.44
Adipocyte - perirenal, donor1	11476-119C9	51.04	26.16
Adipocyte - subcutaneous, donor1	11259-116F8	60.47	27.49
Adipocyte - subcutaneous, donor2	11336-117F4	93.94	13.55
Adipocyte - subcutaneous, donor3	11408-118E4	28.85	16.51
Adipocyte differentiation, day04, donor1	13019-139D4	93.87	40.09
Adipocyte differentiation, day04, donor2	13022-139D7	117.11	35.26
Adipocyte differentiation, day04, donor3	13025-139E1	105.10	38.47
Adipocyte differentiation, day04, donor4	13028-139E4	162.24	49.96
Adipocyte differentiation, day08, donor1	13020-139D5	148.56	91.45
Adipocyte differentiation, day08, donor2	13023-139D8	101.02	46.48
Adipocyte differentiation, day08, donor3	13026-139E2	54.92	34.12
Adipocyte differentiation, day08, donor4	13029-139E5	161.92	65.66
Adipocyte differentiation, day12, donor1	13021-139D6	83.59	46.16
Adipocyte differentiation, day12, donor2	13024-139D9	71.83	34.16
Adipocyte differentiation, day12, donor3	13027-139E3	75.27	45.16
Adipocyte differentiation, day12, donor4	13030-139E6	98.95	60.29
Alveolar Epithelial Cells, donor1	11510-119G7	67.40	14.59
Alveolar Epithelial Cells, donor2	11590-120G6	35.50	4.30
Alveolar Epithelial Cells, donor3	11671-122G6	15.57	5.99
Amniotic Epithelial Cells, donor1	11533-120A3	47.50	15.29
Amniotic Epithelial Cells, donor2	11613-122A2	30.12	5.02
Amniotic Epithelial Cells, donor3	11694-123A2	33.90	8.42
Anulus Pulposus Cell, donor1	11248-116E6	50.35	25.06
Anulus Pulposus Cell, donor2	11463-119B5	42.61	14.94
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	81.32	27.86
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	91.17	21.71
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	66.35	32.10
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	79.81	23.91
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	96.11	21.50
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	64.03	17.16
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	73.10	17.22
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	90.29	19.90
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	56.42	19.60
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	89.26	18.08
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	83.45	11.61
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	51.40	10.03
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	66.55	22.90
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	73.70	24.57
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	67.25	23.37
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	92.16	17.68
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	70.66	14.17
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	74.31	19.24
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	75.11	19.51
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	56.72	13.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	64.84	16.81
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	109.74	28.32
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	65.35	19.73
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	25.17
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	97.57	28.64
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	74.75	15.56
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	61.78	23.02
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	69.54	22.80
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	55.58	17.32
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	60.39	18.07
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	70.38	20.18
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	64.95	17.69
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	49.94	17.12
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	76.63	18.13
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	75.27	21.08
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	64.15	19.01
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	81.37	24.41
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	82.26	24.45
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	54.01	14.61
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	84.15	20.71
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	60.33	17.57
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	56.84	15.66
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	93.53	26.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	54.42	16.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	44.01	18.53
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	111.97	33.80
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	74.19	16.94
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	82.43	18.65
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	76.54	14.58
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	66.90	11.26
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	63.76	10.20
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	80.59	25.17
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	72.87	18.99
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	71.91	18.05
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	80.78	21.99
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	62.75	20.62
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	44.25	13.73
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	74.22	18.83
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	64.61	18.80
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	73.42	19.26
Astrocyte - cerebellum, donor1	11500-119F6	70.87	23.70
Astrocyte - cerebellum, donor2	11580-120F5	39.37	11.81
Astrocyte - cerebellum, donor3	11661-122F5	28.32	7.13
Astrocyte - cerebral cortex, donor1	11235-116D2	89.24	52.29
Astrocyte - cerebral cortex, donor2	11316-117D2	124.89	50.31
Astrocyte - cerebral cortex, donor3	11392-118C6	109.78	48.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	147.71	115.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	174.77	149.59
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	176.04	144.18
Basophils, donor1	12241-129G9	72.18	18.05
Basophils, donor2	12242-129H1	136.74	33.19
Basophils, donor3	12243-129H2	65.12	19.55
Bronchial Epithelial Cell, donor1	11511-119G8	38.81	7.98
Bronchial Epithelial Cell, donor2	11591-120G7	13.72	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	21.52
Bronchial Epithelial Cell, donor4	11453-119A4	78.46	15.69
Bronchial Epithelial Cell, donor5	11457-119A8	41.38	7.49
Bronchial Epithelial Cell, donor6	11461-119B3	50.20	9.90
Bronchial Epithelial Cell, donor7	11769-123I5	79.00	23.93
Burkitt's lymphoma cell line:DAUDI	10422-106C8	81.52	54.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	268.31	168.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	127.27	62.04
CD133+ stem cells - cord blood derived, pool1	12223-129E9	217.18	51.71
CD14+ Monocytes, donor1	11224-116B9	150.47	38.89
CD14+ Monocytes, donor2	11305-117B9	130.66	27.84
CD14+ Monocytes, donor3	11381-118B4	94.18	18.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	44.72	51.51
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	54.59	59.51
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	52.27	69.04
CD14+ monocytes - mock treated, donor1	11863-125A9	119.11	24.43
CD14+ monocytes - mock treated, donor2	11873-125C1	167.77	26.55
CD14+ monocytes - mock treated, donor3	11883-125D2	183.59	33.40
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	120.53	23.27
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	179.96	27.88
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	184.21	27.27
CD14+ monocytes - treated with BCG, donor1	11860-125A6	109.45	19.58
CD14+ monocytes - treated with BCG, donor2	11870-125B7	154.90	25.82
CD14+ monocytes - treated with BCG, donor3	11880-125C8	196.08	37.21
CD14+ monocytes - treated with Candida, donor1	11868-125B5	121.04	22.01
CD14+ monocytes - treated with Candida, donor2	11878-125C6	247.12	29.57
CD14+ monocytes - treated with Candida, donor3	11888-125D7	165.29	42.16
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	110.37	18.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	172.41	26.74
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	215.69	37.27
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	139.56	19.45
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	258.55	46.60
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	194.23	28.37
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	144.45	31.20
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	146.02	31.58
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	182.22	32.82
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	114.08	16.35
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	252.57	35.58
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	253.14	32.90
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	116.66	18.31
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	161.68	30.48
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	228.05	43.11
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	106.47	21.29
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	213.02	33.61
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	192.79	33.41
CD14+CD16+ Monocytes, donor1	11789-124B7	63.65	36.40
CD14+CD16+ Monocytes, donor2	11801-124D1	66.99	32.34
CD14+CD16+ Monocytes, donor3	11912-125G4	64.33	32.28
CD14+CD16- Monocytes, donor1	11788-124B6	92.50	43.29
CD14+CD16- Monocytes, donor2	11799-124C8	83.13	35.98
CD14+CD16- Monocytes, donor3	11910-125G2	183.28	78.71
CD14-CD16+ Monocytes, donor1	11790-124B8	35.21	25.52
CD14-CD16+ Monocytes, donor2	11800-124C9	41.06	30.08
CD14-CD16+ Monocytes, donor3	11911-125G3	49.27	35.79
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	87.39	56.90
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	93.56	44.07
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	97.35	55.92
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	82.09	44.78
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	110.43	76.12
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	98.97	72.30
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	92.55	61.18
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	94.92	64.60
CD19+ B Cells, donor1	11544-120B5	131.50	53.42
CD19+ B Cells, donor2	11624-122B4	121.15	44.98
CD19+ B Cells, donor3	11705-123B4	99.45	40.89
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	444.46	266.27
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	343.96	165.39
CD34+ Progenitors, donor1	11545-120B6	66.27	13.05
CD34+ Progenitors, donor2	11625-122B5	233.71	40.45
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	139.41	61.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	177.91	83.65
CD4+ T Cells, donor1	11225-116C1	156.39	96.76
CD4+ T Cells, donor2	11306-117C1	162.28	60.62
CD4+ T Cells, donor3	11382-118B5	128.71	45.14
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	139.36	84.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	120.83	84.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	117.00	83.08
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	112.36	78.23
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	129.23	69.53
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	102.18	42.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	121.68	70.67
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	100.32	63.38
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	91.24	57.23
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	117.01	60.52
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	108.31	59.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	168.07	77.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	156.01	83.91
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	79.99	56.51
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	87.54	51.79
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	113.40	82.40
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	118.44	80.39
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	100.42	48.42
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	135.36	81.77
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	88.16	61.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	86.37	59.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	111.74	58.14
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	108.31	64.12
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	146.43	88.47
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	116.29	74.73
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	132.94	55.39
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	96.31	68.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	177.51	92.22
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	209.32	115.09
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	163.24	86.24
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	135.37	84.16
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	123.26	96.95
CD8+ T Cells, donor1	11226-116C2	149.62	50.75
CD8+ T Cells, donor2	11307-117C2	162.19	36.42
CD8+ T Cells, donor3	11383-118B6	132.81	46.21
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	128.92	29.36
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	114.79	25.88
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	119.29	40.49
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	126.39	31.52
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	101.75	27.60
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	113.47	23.65
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	104.95	23.47
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	101.86	23.43
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	109.28	29.55
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	103.24	24.75
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	119.98	31.66
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	93.78	22.65
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	99.81	16.20
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	102.93	22.77
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	128.29	20.14
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	134.34	28.45
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	130.91	23.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	113.84	26.87
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	124.54	21.55
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	127.95	26.45
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	117.97	20.52
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	100.21	23.71
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	98.92	20.49
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	121.03	22.69
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	153.36	30.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	161.57	40.57
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	119.21	23.04
Cardiac Myocyte, donor1	11525-119I4	228.47	98.70
Cardiac Myocyte, donor2	11605-120I3	71.64	20.75
Cardiac Myocyte, donor3	11686-122I3	94.50	34.52
Chondrocyte - de diff, donor1	11261-116G1	112.32	26.69
Chondrocyte - de diff, donor2	11338-117F6	50.11	15.64
Chondrocyte - de diff, donor3	11410-118E6	63.72	16.73
Chondrocyte - re diff, donor2	11339-117F7	149.51	66.25
Chondrocyte - re diff, donor3	11411-118E7	48.12	12.94
Ciliary Epithelial Cells, donor1	11242-116D9	117.05	64.61
Ciliary Epithelial Cells, donor2	11323-117D9	110.30	44.25
Ciliary Epithelial Cells, donor3	11399-118D4	102.13	39.47
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	43.92	44.93
Corneal Epithelial Cells, donor1	11526-119I5	33.81	4.83
Corneal Epithelial Cells, donor2	11606-120I4	62.57	17.06
Corneal Epithelial Cells, donor3	11687-122I4	48.83	5.88
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	74.29	73.96
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	62.45	61.50
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	55.21	55.21
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	51.08	38.44
Dendritic Cells - plasmacytoid, donor1	11228-116C4	66.28	48.51
Dendritic Cells - plasmacytoid, donor2	11309-117C4	70.51	56.15
Dendritic Cells - plasmacytoid, donor3	11385-118B8	83.24	55.17
Endothelial Cells - Aortic, donor0	11207-116A1	103.23	18.51
Endothelial Cells - Aortic, donor1	11263-116G3	73.35	14.08
Endothelial Cells - Aortic, donor2	11340-117F8	98.98	20.64
Endothelial Cells - Aortic, donor3	11412-118E8	103.80	22.80
Endothelial Cells - Artery, donor1	11264-116G4	78.54	9.31
Endothelial Cells - Artery, donor2	11341-117F9	127.52	20.94
Endothelial Cells - Artery, donor3	11413-118E9	81.52	14.38
Endothelial Cells - Lymphatic, donor1	11236-116D3	70.71	23.27
Endothelial Cells - Lymphatic, donor2	11317-117D3	95.24	37.73
Endothelial Cells - Lymphatic, donor3	11393-118C7	123.76	38.90
Endothelial Cells - Microvascular, donor1	11265-116G5	58.54	13.97
Endothelial Cells - Microvascular, donor2	11342-117G1	49.98	17.18
Endothelial Cells - Microvascular, donor3	11414-118F1	34.45	7.09
Endothelial Cells - Thoracic, donor1	11266-116G6	296.09	36.81
Endothelial Cells - Thoracic, donor2	11343-117G2	69.18	11.53
Endothelial Cells - Umbilical vein, donor1	11243-116E1	244.89	72.19
Endothelial Cells - Umbilical vein, donor2	11324-117E1	221.39	50.84
Endothelial Cells - Umbilical vein, donor3	11400-118D5	260.62	62.90
Endothelial Cells - Vein, donor1	11267-116G7	53.46	7.96
Endothelial Cells - Vein, donor2	11344-117G3	69.15	8.38
Endothelial Cells - Vein, donor3	11416-118F3	78.66	14.29
Eosinophils, donor1	12244-129H3	106.73	30.49
Eosinophils, donor2	12245-129H4	443.92	128.72
Eosinophils, donor3	12246-129H5	271.08	60.64
Esophageal Epithelial Cells, donor1	11507-119G4	38.85	7.57
Esophageal Epithelial Cells, donor2	11587-120G3	31.20	6.24
Esophageal Epithelial Cells, donor3	11668-122G3	113.88	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	103.45	39.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	30.00	7.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	55.04	16.25
Fibroblast - Aortic Adventitial, donor1	11245-116E3	105.76	39.78
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	86.11	33.44
Fibroblast - Aortic Adventitial, donor2	11326-117E3	66.34	25.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	87.22	19.76
Fibroblast - Aortic Adventitial, donor3	11401-118D6	83.38	27.57
Fibroblast - Cardiac, donor1	11268-116G8	76.66	19.51
Fibroblast - Cardiac, donor2	11345-117G4	75.79	14.40
Fibroblast - Cardiac, donor3	11417-118F4	61.67	20.98
Fibroblast - Cardiac, donor4	11452-119A3	153.98	69.71
Fibroblast - Cardiac, donor5	11456-119A7	117.39	30.96
Fibroblast - Cardiac, donor6	11460-119B2	124.16	37.14
Fibroblast - Choroid Plexus, donor1	11492-119E7	59.09	27.87
Fibroblast - Choroid Plexus, donor2	11572-120E6	58.24	24.59
Fibroblast - Choroid Plexus, donor3	11653-122E6	101.07	27.83
Fibroblast - Conjunctival, donor1	11531-120A1	133.54	20.53
Fibroblast - Conjunctival, donor3	11692-122I9	59.53	31.38
Fibroblast - Dermal, donor1	11269-116G9	90.39	15.50
Fibroblast - Dermal, donor2	11346-117G5	83.49	10.85
Fibroblast - Dermal, donor3	11418-118F5	65.40	13.06
Fibroblast - Dermal, donor4	11450-119A1	133.39	28.37
Fibroblast - Dermal, donor5	11454-119A5	181.43	38.90
Fibroblast - Dermal, donor6	11458-119A9	197.02	41.58
Fibroblast - Gingival, donor1	11237-116D4	102.03	38.31
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	110.56	48.21
Fibroblast - Gingival, donor2	11318-117D4	96.73	31.89
Fibroblast - Gingival, donor3	11394-118C8	92.14	38.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	41.56	28.05
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	60.09	26.61
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	133.29	42.87
Fibroblast - Gingival, donor6 (control)	11922-125H5	112.10	35.02
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	32.46	9.88
Fibroblast - Gingival, donor7 (control)	11924-125H7	136.01	58.79
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	149.03	43.50
Fibroblast - Gingival, donor8 (control)	11926-125H9	236.94	56.49
Fibroblast - Gingival, donor9 (control)	11927-125I1	73.96	44.17
Fibroblast - Lung, donor1	11270-116H1	25.83	9.52
Fibroblast - Lung, donor2	11347-117G6	94.01	23.87
Fibroblast - Lung, donor3	11419-118F6	81.25	18.57
Fibroblast - Lymphatic, donor1	11506-119G3	158.27	19.16
Fibroblast - Lymphatic, donor2	11586-120G2	54.55	9.79
Fibroblast - Lymphatic, donor3	11667-122G2	18.75	2.80
Fibroblast - Mammary, donor1	11540-120B1	107.18	21.11
Fibroblast - Mammary, donor2	11620-122A9	75.89	15.98
Fibroblast - Mammary, donor3	11701-123A9	77.43	23.83
Fibroblast - Periodontal Ligament, donor1	11238-116D5	118.91	37.63
Fibroblast - Periodontal Ligament, donor2	11319-117D5	174.59	50.36
Fibroblast - Periodontal Ligament, donor3	11395-118C9	255.81	66.71
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	120.21	35.87
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	78.30	29.16
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	70.63	23.54
Fibroblast - Pulmonary Artery, donor1	11250-116E8	127.22	40.90
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	67.87	18.90
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	58.80	14.03
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	55.35	22.14
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	109.74	26.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	68.56	23.98
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	109.78	29.56
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	91.16	22.56
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	144.01	45.66
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	77.44	25.05
Fibroblast - skin normal, donor1	11553-120C5	66.78	28.22
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	107.87	31.68
Fibroblast - skin normal, donor2	11561-120D4	112.22	40.29
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	109.11	29.01
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	87.15	40.76
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	90.95	40.69
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	74.55	18.06
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	116.53	29.61
Fibroblast - skin walker warburg, donor1	11554-120C6	81.14	20.07
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	64.30	17.72
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1329.59	288.08
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	333.80	54.91
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	111.12	26.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	106.96	22.38
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	170.68	39.60
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	128.61	62.78
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	119.96	66.36
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	163.17	124.95
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	113.61	60.39
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	86.54	60.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	104.61	77.87
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	98.86	55.25
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	99.15	60.01
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	129.13	97.73
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	107.12	60.20
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	93.22	59.35
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	99.12	54.80
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	128.85	44.48
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	124.45	42.91
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	123.40	44.73
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	86.02	38.56
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	97.78	36.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	95.30	39.34
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	94.85	44.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	98.87	50.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	68.14	35.97
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	92.35	50.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	113.83	54.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	127.60	66.95
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	89.90	61.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	92.05	50.38
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	91.84	48.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	104.58	58.40
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	119.24	59.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	78.60	41.05
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	79.78	48.54
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	86.88	43.69
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	75.17	44.31
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	82.65	51.04
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	86.72	46.36
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	73.76	43.62
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	64.24	37.33
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	87.63	34.01
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	68.72	38.01
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	78.61	38.89
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	76.62	34.69
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	73.50	33.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	87.12	40.92
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	93.32	43.59
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	109.70	44.68
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	83.68	40.29
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	81.59	41.20
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	71.34	45.17
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	56.58	39.70
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	119.01	80.33
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	69.78	31.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	66.98	31.27
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	75.74	74.72
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	177.96	103.51
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	127.42	71.18
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	170.83	94.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	104.83	70.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	93.53	65.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	142.05	71.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	128.69	79.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	155.11	84.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	118.73	65.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	116.50	52.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	125.31	64.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	136.72	73.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	119.96	66.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	137.87	66.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	117.34	69.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	101.50	44.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	122.78	69.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	139.26	59.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	83.53	41.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	133.44	68.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	96.19	59.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	108.43	54.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	164.85	78.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	150.73	84.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	47.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	101.10	57.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	126.15	69.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	90.96	51.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	113.27	64.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	248.20	107.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	94.42	62.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	143.44	84.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	127.94	70.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	124.63	65.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	113.67	74.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	132.22	69.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	119.22	61.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	109.10	57.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	96.12	53.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	78.84	52.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	85.36	34.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	99.48	40.28
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	21.68	6.85
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	45.32	22.87
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	26.99	7.87
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	37.11	23.47
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	21.72	13.37
Hep-2 cells mock treated, biol_rep1	11898-125E8	174.64	59.65
Hep-2 cells mock treated, biol_rep2	11899-125E9	209.99	65.66
Hep-2 cells mock treated, biol_rep3	11900-125F1	216.36	56.19
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	181.02	63.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	194.50	57.38
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	206.46	58.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	163.14	55.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	184.59	55.58
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	200.55	51.26
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	54.84	15.67
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	45.01	8.22
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	129.55	21.15
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	63.14	13.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	31.97	13.80
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	112.60	26.93
Hepatocyte, donor1	11523-119I2	156.17	88.37
Hepatocyte, donor2	11603-120I1	224.09	65.72
Hepatocyte, donor3	11684-122I1	189.58	84.05
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	116.83	82.89
Intestinal epithelial cells (polarized), donor1	11246-116E4	164.29	62.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	106.47	35.40
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	73.23	9.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	59.53	16.61
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	37.54	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	23.74
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	69.20	25.63
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	59.42	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	71.47	27.61
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	81.70	21.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	47.20	14.52
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	66.17	17.21
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	62.08	17.74
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	94.29	15.71
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	68.03	31.49
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	55.68	12.37
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	102.44	29.27
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	59.44	20.03
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	43.47	12.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	191.17	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	61.93	25.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	37.78	13.01
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	71.86	57.49
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	72.33	20.09
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	62.78	16.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	105.57	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	66.09	24.55
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	62.58	12.70
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	132.68	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	49.50	21.52
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	67.33	19.06
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	46.55	19.77
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	54.68	18.23
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	158.04	31.61
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	39.99	13.57
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	63.05	19.91
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	145.94	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	84.88	30.56
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	75.51	22.83
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	59.72	22.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	50.07	15.30
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	61.97	13.28
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	90.78	22.69
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	40.98	13.95
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	76.49	20.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	55.75	17.42
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	40.54	14.93
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	47.11	16.63
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	37.04	34.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	49.70	13.81
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	31.04
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	57.10	9.52
Keratinocyte - epidermal, donor1	11272-116H3	117.42	32.23
Keratinocyte - epidermal, donor2	11349-117G8	50.95	6.44
Keratinocyte - epidermal, donor3	11421-118F8	118.51	26.31
Keratinocyte - oral, donor1	11251-116E9	125.10	40.41
Keratocytes, donor1	11527-119I6	144.41	26.13
Keratocytes, donor2	11607-120I5	70.31	10.55
Keratocytes, donor3	11688-122I5	91.69	32.80
Krukenberg tumor cell line:HSKTC	10687-109F3	956.09	200.01
Lens Epithelial Cells, donor1	11529-119I8	110.03	26.97
Lens Epithelial Cells, donor2	11609-120I7	75.43	37.71
Lens Epithelial Cells, donor3	11690-122I7	148.64	64.68
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	56.92	20.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	54.98	15.91
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	96.34	26.76
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	65.60	13.98
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	46.33	12.29
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	39.03	11.86
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	89.88	20.93
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	27.05	6.83
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	50.39	15.48
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	79.50	14.24
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	52.15	12.02
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	22.40	5.55
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	77.35	17.07
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	57.96	13.83
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	41.89	11.13
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	90.85	22.48
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	32.42	6.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	48.86	12.08
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	68.13	16.78
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	34.27	8.20
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	31.37	8.71
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	85.35	17.46
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	57.36	19.12
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	54.19	10.90
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	66.36	16.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	76.85	18.22
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	48.27	11.28
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	79.11	19.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	44.78	12.04
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	30.32	7.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	83.35	19.38
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	46.97	14.22
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	29.86	7.81
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	102.92	29.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	59.05	15.07
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	28.60	8.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	88.13	17.37
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	72.43	19.78
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	63.54	20.58
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	80.00	19.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	33.93	3.88
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	21.47	5.76
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	76.99	18.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	45.41	15.03
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	23.54	7.06
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	79.94	26.48
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	27.66	5.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	50.12	11.04
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	13.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.95	10.74
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	26.72	5.20
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	27.08	13.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.88	8.44
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	23.35	11.21
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	23.70	10.31
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	16.65	9.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	18.32	8.14
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	55.84	17.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	58.07	22.51
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	27.50	11.52
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	25.68	8.22
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	47.64	19.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	47.97	15.99
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	34.64	18.34
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	48.03	21.08
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	64.24	23.43
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	31.29	9.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	34.25	9.79
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	69.14	25.41
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	74.83	22.70
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	34.00	10.30
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	46.74	17.71
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	61.88	20.63
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	47.58	15.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	37.12	11.31
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	49.79	16.23
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	36.84	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	32.24	9.98
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	24.34	11.32
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	41.84	13.95
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	25.31	6.33
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	35.91	13.64
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	43.32	11.95
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	29.73	8.92
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	46.52	16.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	34.25	11.99
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	34.32	14.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	38.01	7.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.77	7.82
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	25.09	11.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	24.69	10.20
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	22.89	10.10
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	29.63	12.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	40.70	5.81
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	21.15	12.69
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	32.81	9.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	19.63	5.81
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	24.53	8.43
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	18.74	4.93
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	25.41	13.17
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	24.14	6.54
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	27.04	7.21
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	39.59	17.21
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	30.28	10.24
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	26.98	8.60
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	31.01	9.90
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	33.73	10.90
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	37.63	12.69
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	54.79	15.65
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	41.96	11.04
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	40.11	13.89
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	41.01	7.09
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	47.10	13.94
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	25.44	9.94
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	49.82	15.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	42.89	13.14
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	41.80	13.68
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	40.80	8.78
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	42.33	8.47
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	36.76	17.75
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	36.25	9.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	31.03	4.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	34.45	9.26
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	42.44	12.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	37.45	5.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	27.04	12.06
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	43.07	11.75
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	41.75	10.02
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	34.38	7.90
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	44.16	11.37
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	43.31	9.62
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	28.69	9.29
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	21.11	5.51
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	40.01	7.11
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	36.47	6.27
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	31.44	6.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	67.85	18.06
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	32.96	11.14
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	33.27	10.92
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	55.04	8.62
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	8.31
Macrophage - monocyte derived, donor1	11232-116C8	34.42	38.52
Macrophage - monocyte derived, donor2	11313-117C8	55.05	46.98
Macrophage - monocyte derived, donor3	11389-118C3	45.75	35.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	87.62	17.52
Mallassez-derived cells, donor2	11929-125I3	158.14	35.33
Mallassez-derived cells, donor3	11930-125I4	197.22	31.27
Mammary Epithelial Cell, donor1	11273-116H4	211.84	41.55
Mammary Epithelial Cell, donor2	11350-117G9	163.31	36.48
Mammary Epithelial Cell, donor3	11422-118F9	32.67	6.49
Mast cell - stimulated, donor1	11487-119E2	649.46	320.66
Mast cell, donor1	11563-120D6	93.87	57.10
Mast cell, donor2	11565-120D8	112.93	70.13
Mast cell, donor3	11566-120D9	103.11	70.69
Mast cell, donor4	11567-120E1	92.90	73.22
Mast cell, expanded and stimulated, donor5	11940-126A5	141.83	75.19
Mast cell, expanded and stimulated, donor8	11942-126A7	215.96	82.88
Mast cell, expanded, donor5	11939-126A4	68.37	56.21
Mast cell, expanded, donor8	11941-126A6	101.93	61.59
Melanocyte - dark, donor1	11502-119F8	119.40	53.43
Melanocyte - dark, donor2	11582-120F7	70.60	25.96
Melanocyte - dark, donor3	11663-122F7	79.76	45.57
Melanocyte - light, donor1	11274-116H5	23.51	5.41
Melanocyte - light, donor2	11351-117H1	6.82	5.46
Melanocyte - light, donor3	11423-118G1	13.01	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	65.91	38.63
Melanocyte, donor2 (MC+2)	12739-135I3	64.28	37.92
Melanocyte, donor3 (MC+3)	12837-137B2	53.30	46.87
Meningeal Cells, donor1	11493-119E8	140.93	38.46
Meningeal Cells, donor2	11573-120E7	96.83	32.13
Meningeal Cells, donor3	11654-122E7	179.71	63.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	95.81	30.23
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	90.57	34.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	22.34	10.51
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	43.17	22.24
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	138.50	25.83
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	67.34	30.71
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	82.43	33.17
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	48.57	10.11
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	62.10	12.42
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	42.76	8.39
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	61.77	27.70
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	28.99	12.27
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	91.58	44.08
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	31.16	14.24
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	49.05	11.68
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	47.39	12.17
Mesenchymal stem cells - adipose, donor0	11217-116B2	158.79	30.48
Mesenchymal stem cells - hepatic, donor0	11218-116B3	71.93	40.03
Mesenchymal stem cells - umbilical, donor0	11214-116A8	113.93	22.50
Mesothelial Cells, donor1	11247-116E5	57.81	24.93
Mesothelial Cells, donor2	12156-128G5	88.58	34.03
Mesothelial Cells, donor3	11402-118D7	71.61	19.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	438.86	248.46
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	72.65	51.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	49.47	44.76
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	148.65	51.86
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	42.77	32.54
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	36.51	32.77
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	238.55	78.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	49.05	37.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	70.75	45.62
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	330.92	116.80
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	36.58	32.92
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	48.70	26.93
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	572.95	85.51
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	28.32	18.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	45.21	33.81
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	214.49	85.53
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	33.32	25.89
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	90.24	46.96
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	51.27	30.40
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	248.15	88.86
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	950.58	203.70
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	45.92	25.59
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	46.58	39.22
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	176.37	56.39
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	42.60	21.18
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	43.33	31.34
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	44.43	22.01
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	46.77	23.38
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	65.58	39.79
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	412.74	30.96
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	44.46	16.43
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	120.66	64.89
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	253.52	74.56
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	73.11	31.80
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	67.64	42.94
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	246.41	57.79
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	42.77	16.34
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	48.03	32.42
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	276.99	63.08
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	62.57	19.02
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	80.84
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	348.58	46.89
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	80.58	27.59
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	188.72	70.63
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	215.81	58.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	87.27	29.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	136.40	45.93
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	413.25	88.39
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	50.94	21.54
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	97.59	43.32
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	222.29	50.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	53.02	20.48
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	71.49	34.50
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	201.05	53.03
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	62.75	19.61
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	78.47	30.89
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	368.16	36.09
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	74.81	16.62
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	103.58	47.81
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	76.00	36.20
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	53.13	18.40
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	110.25	35.61
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	130.85	31.12
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	87.01	32.03
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	58.67	29.63
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	59.89	20.62
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	54.78	25.16
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	65.68	30.74
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	102.00	34.89
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	70.74	21.31
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	52.85	23.11
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	129.68	25.42
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	65.86	26.76
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	57.95	22.49
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	81.60	40.80
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	59.85	22.93
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	18.83
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	42.77	32.08
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	35.16	32.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	34.71	21.04
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	37.56	37.56
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	69.85	42.84
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	51.45	38.30
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	30.90	23.44
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	47.62	34.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	30.94	13.26
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	40.67	30.05
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	48.22	45.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	50.24	40.62
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	19.32
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	36.36	19.19
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	41.74	33.31
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	66.74	29.96
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	32.43	19.07
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	45.35	33.20
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	66.46	15.10
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	268.38	74.23
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	231.63	78.30
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	80.79	57.03
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	62.75
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	102.98	45.03
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	120.72	62.71
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	64.75	20.02
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	83.47	15.03
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	127.78	21.11
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	754.84	89.37
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	32.64	7.48
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	582.53	99.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	28.46	7.95
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	45.79	10.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	33.24	9.73
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	89.14	27.54
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	957.59	211.56
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	30.77	14.89
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	35.19	8.66
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	20.63	9.75
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	32.33	8.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	76.55	32.44
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	30.23	11.67
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	36.02	10.81
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	92.87	20.02
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	13.82	7.64
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	155.04	56.80
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	21.10	9.85
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	35.40	9.65
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	30.53	10.93
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	85.53	23.45
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	950.70	262.96
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	131.44	51.69
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	39.80	19.48
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	42.49	11.39
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	23.18	11.16
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1137.50	297.92
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	58.98	16.66
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	169.07	50.50
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	38.49	18.65
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	43.65	18.57
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	56.00	21.19
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	35.85	21.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	40.09	17.43
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	230.67	77.34
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	41.45	21.17
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.26	13.30
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	35.72	11.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	47.09	17.23
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	32.36	18.45
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	134.38	49.51
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	35.24	12.20
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	705.12	173.72
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	32.31	24.39
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	53.19	23.29
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	31.48	9.68
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	25.32	17.41
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	190.45	39.68
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	490.62	227.60
Myoblast, donor1	11241-116D8	110.19	38.01
Myoblast, donor2	11322-117D8	96.09	33.75
Myoblast, donor3	11398-118D3	103.25	38.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	170.45	59.10
Natural Killer Cells, donor1	11230-116C6	147.30	49.51
Natural Killer Cells, donor2	11311-117C6	137.21	37.09
Natural Killer Cells, donor3	11387-118C1	121.84	39.02
Neural stem cells, donor1	11275-116H6	214.86	122.31
Neural stem cells, donor2	11352-117H2	171.38	129.02
Neurons, donor1	11494-119E9	143.38	87.62
Neurons, donor2	11574-120E8	66.71	68.47
Neurons, donor3	11655-122E8	173.48	99.48
Neutrophils, donor1	11233-116C9	109.50	62.18
Neutrophils, donor2	11314-117C9	72.47	40.58
Neutrophils, donor3	11390-118C4	161.87	84.30
Nucleus Pulposus Cell, donor1	11252-116F1	57.82	43.22
Nucleus Pulposus Cell, donor2	11409-118E5	24.42	18.23
Nucleus Pulposus Cell, donor3	11462-119B4	68.79	20.86
Olfactory epithelial cells, donor1	11933-125I7	59.19	27.26
Olfactory epithelial cells, donor2	11934-125I8	95.39	36.19
Olfactory epithelial cells, donor3	11935-125I9	75.25	38.82
Olfactory epithelial cells, donor4	11936-126A1	76.26	36.82
Oligodendrocyte - precursors, donor1	11496-119F2	146.84	33.70
Osteoblast - differentiated, donor1	11276-116H7	33.39	23.82
Osteoblast - differentiated, donor2	11353-117H3	16.00	11.43
Osteoblast - differentiated, donor3	11425-118G3	31.04	15.52
Osteoblast, donor1	11277-116H8	38.31	7.04
Osteoblast, donor2	11354-117H4	157.32	39.33
Osteoblast, donor3	11426-118G4	75.89	18.13
Pancreatic stromal cells, donor1	11249-116E7	76.40	28.22
Pericytes, donor1	11491-119E6	18.36	7.23
Pericytes, donor2	11571-120E5	18.34	8.60
Pericytes, donor3	11652-122E5	38.25	11.80
Perineurial Cells, donor1	11499-119F5	115.73	39.78
Perineurial Cells, donor2	11579-120F4	106.82	44.53
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	144.07	73.63
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	93.54	44.32
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	81.79	36.24
Placental Epithelial Cells, donor1	11278-116H9	45.44	6.94
Placental Epithelial Cells, donor2	11355-117H5	33.27	12.20
Placental Epithelial Cells, donor3	11427-118G5	29.65	10.01
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	32.91	8.86
Preadipocyte - breast, donor1	11467-119B9	75.79	38.46
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	59.13	33.28
Preadipocyte - breast, donor2	11328-117E5	61.92	27.02
Preadipocyte - omental, donor1	11468-119C1	88.66	42.84
Preadipocyte - omental, donor2	11329-117E6	72.45	41.46
Preadipocyte - omental, donor3	11403-118D8	91.39	33.81
Preadipocyte - perirenal, donor1	11469-119C2	41.34	6.89
Preadipocyte - subcutaneous, donor1	11279-116I1	43.92	11.98
Preadipocyte - subcutaneous, donor2	11356-117H6	176.37	45.69
Preadipocyte - subcutaneous, donor3	11428-118G6	94.34	21.80
Preadipocyte - visceral, donor1	11280-116I2	162.73	39.22
Preadipocyte - visceral, donor2	11357-117H7	118.27	41.42
Preadipocyte - visceral, donor3	11429-118G7	117.76	22.99
Prostate Epithelial Cells (polarized), donor1	11253-116F2	183.13	58.23
Prostate Epithelial Cells, donor2	11331-117E8	62.56	16.52
Prostate Epithelial Cells, donor3	11404-118D9	98.90	22.72
Prostate Stromal Cells, donor1	11254-116F3	107.18	40.66
Prostate Stromal Cells, donor2	11332-117E9	135.37	29.94
Prostate Stromal Cells, donor3	11405-118E1	45.36	24.61
Renal Cortical Epithelial Cells, donor1	11516-119H4	45.62	9.12
Renal Cortical Epithelial Cells, donor2	11596-120H3	85.11	29.53
Renal Epithelial Cells, donor1	11517-119H5	37.03	12.17
Renal Epithelial Cells, donor2	11597-120H4	54.06	16.36
Renal Epithelial Cells, donor3	11678-122H4	129.37	44.15
Renal Glomerular Endothelial Cells, donor1	11514-119H2	42.89	9.53
Renal Glomerular Endothelial Cells, donor2	11594-120H1	67.38	11.99
Renal Glomerular Endothelial Cells, donor3	11675-122H1	171.61	41.96
Renal Glomerular Endothelial Cells, donor4	11783-124B1	43.92	15.31
Renal Mesangial Cells, donor1	11518-119H6	43.58	15.63
Renal Mesangial Cells, donor2	11598-120H5	50.79	10.03
Renal Mesangial Cells, donor3	11679-122H5	24.69	5.27
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	105.22	20.13
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	65.36	7.59
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	50.14	14.46
Retinal Pigment Epithelial Cells, donor0	11215-116A9	86.86	28.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	54.01	18.19
Retinal Pigment Epithelial Cells, donor2	11608-120I6	63.81	13.38
Retinal Pigment Epithelial Cells, donor3	11689-122I6	181.16	66.24
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	112.39	82.72
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	134.01	67.01
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	132.09	75.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	303.37	128.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	272.01	129.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	124.13	75.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	128.60	91.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	169.07	109.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	125.75	73.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	160.87	95.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	166.89	65.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	113.76	75.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	113.43	86.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	140.87	53.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	97.44	70.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	122.14	73.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	214.88	62.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	121.58	72.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	168.18	117.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	221.22	79.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	126.35	77.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	134.82	77.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	169.91	63.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	126.14	69.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	147.31	82.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	176.50	66.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	116.87	62.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	111.08	72.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	205.92	62.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	116.07	72.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	126.04	78.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	161.74	61.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	155.07	68.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	142.46	78.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	187.07	76.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	184.26	95.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	173.90	99.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	183.29	61.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	139.23	87.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	142.83	96.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	151.00	54.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	106.83	67.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	138.07	90.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	131.08	48.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	74.05	54.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	170.30	108.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	88.62	37.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	103.06	58.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	130.56	68.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	92.65	36.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	178.16	105.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	86.40	46.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	100.37	37.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	77.13	38.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	93.16	53.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	105.09	46.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	69.80	38.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	96.16	51.08
Schwann Cells, donor1	11498-119F4	39.87	8.65
Schwann Cells, donor2	11578-120F3	74.85	20.41
Schwann Cells, donor3	11659-122F3	79.53	23.00
Sebocyte, donor1	11220-116B5	105.72	21.91
Sebocyte, donor2	11301-117B5	93.75	21.14
Sebocyte, donor3	11378-118B1	41.84	12.57
Sertoli Cells, donor1	11255-116F4	74.55	21.54
Sertoli Cells, donor2	11333-117F1	96.03	56.49
Skeletal Muscle Cells, donor1	11281-116I3	110.68	35.98
Skeletal Muscle Cells, donor2	11358-117H8	17.35	5.06
Skeletal Muscle Cells, donor3	11430-118G8	35.95	11.70
Skeletal Muscle Cells, donor4	11451-119A2	124.42	36.29
Skeletal Muscle Cells, donor5	11455-119A6	114.90	37.01
Skeletal Muscle Cells, donor6	11459-119B1	167.91	41.09
Skeletal Muscle Satellite Cells, donor1	11240-116D7	113.66	46.75
Skeletal Muscle Satellite Cells, donor2	11321-117D7	98.03	32.25
Skeletal Muscle Satellite Cells, donor3	11397-118D2	157.74	48.22
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	106.66	55.27
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	55.73	12.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	23.67	7.98
Skin - palm, donor1	10286-104F7	601.69	112.82
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	50.31	9.37
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	211.83	36.81
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	54.53	9.35
Small Airway Epithelial Cells, donor1	11256-116F5	141.09	31.97
Small Airway Epithelial Cells, donor2	11334-117F2	185.10	32.35
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	172.12	47.58
Small Airway Epithelial Cells, donor3	11406-118E2	151.03	33.73
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	87.64	10.49
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	77.59	14.90
Smooth Muscle Cells - Aortic, donor0	11210-116A4	45.85	10.58
Smooth Muscle Cells - Aortic, donor1	11283-116I5	47.07	9.28
Smooth Muscle Cells - Aortic, donor2	11360-117I1	55.13	8.27
Smooth Muscle Cells - Aortic, donor3	11432-118H1	58.72	7.73
Smooth Muscle Cells - Bladder, donor1	11519-119H7	72.05	34.03
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	51.50	10.51
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	82.23	24.83
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	86.16	26.89
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	61.21	39.72
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	90.37	57.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	56.38	29.33
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	29.61	7.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	84.33	37.14
Smooth Muscle Cells - Carotid, donor1	11285-116I7	38.64	11.62
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	12.24
Smooth Muscle Cells - Carotid, donor3	11434-118H3	31.95	3.34
Smooth Muscle Cells - Colonic, donor1	11239-116D6	66.36	33.33
Smooth Muscle Cells - Colonic, donor2	11320-117D6	78.99	32.07
Smooth Muscle Cells - Colonic, donor3	11396-118D1	82.08	32.01
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	50.89	12.53
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	47.43	10.78
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	59.77	10.46
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	47.11	15.70
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	89.76	39.11
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	113.93	31.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	83.06	21.16
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	28.98	4.23
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	239.76	90.07
Smooth Muscle Cells - Prostate, donor1	11257-116F6	113.32	38.08
Smooth Muscle Cells - Prostate, donor2	11335-117F3	79.01	36.31
Smooth Muscle Cells - Prostate, donor3	11465-119B7	29.17	13.70
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	88.81	21.71
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	21.00	7.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	90.46	19.38
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	52.55	12.56
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	78.26	13.63
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	53.59	8.78
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.99	6.19
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	213.68	57.32
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	53.72	38.31
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	59.44	12.95
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	48.70	12.75
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	41.18	9.59
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	149.39	41.78
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	99.04	34.69
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	30.95	6.67
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	45.75	13.21
Smooth Muscle Cells - Uterine, donor1	11258-116F7	169.03	39.77
Smooth Muscle Cells - Uterine, donor3	11466-119B8	53.54	18.43
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	52.67	24.10
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	75.90	19.83
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	66.95	23.80
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	76.54	29.47
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	89.71	23.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	228.84	35.05
Smooth muscle cells - airway, control, donor1	11966-126D4	67.55	21.08
Smooth muscle cells - airway, control, donor2	11967-126D5	49.91	17.57
Smooth muscle cells - airway, control, donor3	11968-126D6	40.13	21.74
Smooth muscle cells - airway, control, donor4	11969-126D7	45.84	22.92
Synoviocyte, donor1	11291-117A4	123.21	29.96
Synoviocyte, donor2	11368-117I9	43.25	15.42
Synoviocyte, donor3	11440-118H9	53.62	10.50
Trabecular Meshwork Cells, donor1	11532-120A2	69.32	15.72
Trabecular Meshwork Cells, donor2	11612-122A1	81.26	25.77
Trabecular Meshwork Cells, donor3	11693-123A1	46.31	15.05
Tracheal Epithelial Cells, donor1	11292-117A5	84.16	23.58
Tracheal Epithelial Cells, donor2	11369-118A1	23.58	3.48
Tracheal Epithelial Cells, donor3	11441-118I1	34.36	3.44
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	112.20	83.90
Urethra, donor2	10319-105A4	237.39	118.70
Urothelial Cells, donor1	11520-119H8	32.68	7.97
Urothelial Cells, donor2	11600-120H7	24.03	6.01
Urothelial Cells, donor3	11681-122H7	22.46	2.98
Urothelial cells, donor0	11216-116B1	71.77	22.29
Whole blood (ribopure), donor090309, donation1	12179-129A1	114.78	57.84
Whole blood (ribopure), donor090309, donation2	12180-129A2	138.67	74.34
Whole blood (ribopure), donor090309, donation3	12181-129A3	65.71	32.86
Whole blood (ribopure), donor090325, donation1	12176-128I7	76.10	51.65
Whole blood (ribopure), donor090325, donation2	12177-128I8	85.41	49.97
Whole blood (ribopure), donor090612, donation1	12182-129A4	129.11	55.19
Whole blood (ribopure), donor090612, donation2	12183-129A5	125.74	62.41
Whole blood (ribopure), donor090612, donation3	12184-129A6	44.73	37.43
Wilms' tumor cell line:G-401	10809-111A8	145.69	69.82
Wilms' tumor cell line:HFWT	10597-108E3	307.13	129.37
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	177.93	86.59
achilles tendon, donor2	10292-104G4	204.59	57.86
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	254.45	98.92
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	218.48	115.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	176.76	83.57
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	223.13	151.02
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	245.39	114.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	142.33	81.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	265.13	57.16
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	133.07	39.66
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	189.07	64.93
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	178.62	74.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	307.28	144.07
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	468.06	144.32
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	214.49	81.57
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	401.82	108.48
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	312.12	105.79
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	320.68	98.53
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	192.06	75.26
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	139.97	61.39
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	139.53	96.86
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	143.76	100.09
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	151.64	111.69
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	256.59	70.16
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	504.32	162.77
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1646.37	373.50
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	211.31	118.27
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	353.70	155.70
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1424.59	286.79
adenocarcinoma cell line:IM95m	10796-110I4	175.92	55.34
adipose tissue, adult, pool1	10010-101C1	87.33	62.20
adipose, donor1	10184-103D4	288.51	168.30
adipose, donor2	10185-103D5	40.15	36.09
adipose, donor3	10186-103D6	81.69	56.36
adipose, donor4	10187-103D7	116.14	75.41
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	169.03	140.14
adrenal gland, adult, pool1	10081-102A9	87.30	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	110.19	67.10
alveolar cell carcinoma cell line:SW 1573	10708-109H6	184.37	55.38
amniotic membrane cells, donor1	12235-129G3	117.78	32.23
amniotic membrane cells, donor2	12236-129G4	51.05	42.26
amniotic membrane cells, donor3	12237-129G5	98.99	40.95
amygdala - adult, donor10196	10167-103B5	126.88	112.65
amygdala, adult, donor10252	10151-102I7	104.43	119.63
amygdala, newborn, donor10223	10360-105E9	156.54	82.63
anaplastic carcinoma cell line:8305C	10428-106D5	114.85	42.78
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	122.45	34.64
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	198.75	65.81
aorta, adult, pool1	10052-101G7	61.19	32.95
appendix, adult	10189-103D9	157.96	95.87
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	199.83	66.38
artery, adult	10190-103E1	184.78	86.96
astrocytoma cell line:TM-31	10425-106D2	255.69	98.08
b cell line:RPMI1788	10427-106D4	114.20	70.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	77.96	22.75
bile duct carcinoma cell line:HuCCT1	10432-106D9	208.88	50.21
bile duct carcinoma cell line:TFK-1	10496-107C1	882.42	201.69
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	163.86	60.96
bladder, adult, pool1	10011-101C2	120.92	75.51
blood, adult, pool1	10053-101G8	35.43	31.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	229.50	49.67
bone marrow, adult	10192-103E3	128.22	75.58
brain, adult, donor1	10084-102B3	22.55	28.70
brain, adult, pool1	10012-101C3	71.60	90.31
brain, fetal, pool1	10085-102B4	32.06	40.07
breast carcinoma cell line:MCF7	10482-107A5	193.26	97.79
breast carcinoma cell line:MDA-MB-453	10419-106C5	241.03	155.28
breast, adult, donor1	10080-102A8	102.91	54.93
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	224.60	101.50
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	249.85	57.51
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	85.18	36.37
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	145.98	66.82
carcinoid cell line:NCI-H1770	10703-109H1	141.05	196.53
carcinoid cell line:NCI-H727	10735-110B6	181.02	59.72
carcinoid cell line:SK-PN-DW	10719-109I8	150.53	81.44
carcinosarcoma cell line:JHUCS-1	10642-109A3	158.91	103.81
caudate nucleus - adult, donor10196	10177-103C6	140.46	107.07
caudate nucleus, adult, donor10252	10164-103B2	80.48	75.30
caudate nucleus, adult, donor10258	10379-105H1	99.34	94.75
caudate nucleus, newborn, donor10223	10354-105E3	172.86	83.13
cerebellum - adult, donor10196	10173-103C2	174.80	221.41
cerebellum, adult, donor10252	10166-103B4	96.29	147.96
cerebellum, adult, pool1	10083-102B2	43.12	57.95
cerebellum, newborn, donor10223	10357-105E6	267.35	199.27
cerebral meninges, adult	10188-103D8	114.98	106.91
cerebrospinal fluid, donor2	10294-104G6	233.88	89.90
cervical cancer cell line:D98-AH2	10552-107I3	225.88	77.93
cervical cancer cell line:ME-180	10553-107I4	233.33	73.25
cervix, adult, pool1	10013-101C4	101.95	77.06
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	122.06	68.14
chondrosarcoma cell line:SW 1353	10700-109G7	423.23	57.48
choriocarcinoma cell line:BeWo	10423-106C9	167.03	93.21
choriocarcinoma cell line:SCH	10785-110H2	355.34	78.98
choriocarcinoma cell line:T3M-3	10618-108G6	216.31	64.75
chorionic membrane cells, donor1	12238-129G6	66.10	19.09
chorionic membrane cells, donor2	12239-129G7	82.53	34.30
chorionic membrane cells, donor3	12240-129G8	84.62	25.83
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	117.14	45.44
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	158.29	58.59
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	207.81	95.67
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	366.71	175.91
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	444.81	201.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	465.86	184.27
chronic myelogenous leukemia cell line:K562	10454-106G4	341.27	166.07
chronic myelogenous leukemia cell line:KU812	10409-106B4	428.47	178.53
clear cell carcinoma cell line:JHOC-5	10638-108I8	79.55	36.12
clear cell carcinoma cell line:TEN	10636-108I6	173.51	65.76
colon carcinoma cell line:CACO-2	10513-107D9	233.74	96.65
colon carcinoma cell line:COLO-320	10420-106C6	295.70	90.08
colon, adult, donor1	10082-102B1	69.02	30.94
colon, adult, pool1	10014-101C5	107.05	61.57
colon, fetal, donor1	10070-101I7	77.87	45.73
common myeloid progenitor CMP, donor1	12130-128D6	838.78	330.01
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	257.51	87.54
cord blood derived cell line:COBL-a 24h infection	10453-106G3	153.20	68.82
cord blood derived cell line:COBL-a untreated	10449-106F8	172.17	73.04
corpus callosum, adult, pool1	10042-101F6	65.45	109.24
cruciate ligament, donor2	10295-104G7	212.34	69.70
diaphragm, fetal, donor1	10069-101I6	156.50	75.44
diencephalon, adult	10193-103E4	71.76	81.84
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	169.68	74.16
ductal cell carcinoma cell line:KLM-1	10438-106E6	407.48	132.58
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	119.64	42.85
ductus deferens, adult	10196-103E7	126.08	76.25
duodenum, fetal, donor1, tech_rep1	10071-101I8	80.65	36.01
duodenum, fetal, donor1, tech_rep2	10071-101I8	126.53	52.97
dura mater, adult, donor1	10041-101F5	82.34	52.61
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	251.39	43.08
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	152.61	65.63
embryonic pancreas cell line:1B2C6	10604-108F1	485.28	106.67
embryonic pancreas cell line:1C3D3	10605-108F2	210.08	62.36
embryonic pancreas cell line:1C3IKEI	10606-108F3	443.06	111.77
embryonic pancreas cell line:2C6	10603-108E9	501.74	95.88
endometrial carcinoma cell line:OMC-2	10497-107C2	279.55	93.52
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	141.36	66.69
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	72.85	48.89
epidermoid carcinoma cell line:A431	10426-106D3	363.16	115.49
epidermoid carcinoma cell line:Ca Ski	10431-106D8	169.16	49.82
epididymis, adult	10197-103E8	67.82	54.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	115.32	66.88
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	165.16	57.41
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	429.84	143.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	325.28	106.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	427.28	163.12
esophagus, adult, pool1	10015-101C6	124.02	54.89
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	205.26	195.24
eye - muscle inferior rectus, donor1	10272-104E2	338.04	115.90
eye - muscle lateral, donor2	10298-104H1	347.19	98.90
eye - muscle medial, donor2	10299-104H2	285.74	120.55
eye - muscle superior, donor2	10297-104G9	251.08	82.55
eye - vitreous humor, donor1	10268-104D7	154.48	39.35
eye, fetal, donor1	10054-101G9	48.30	48.05
fibrosarcoma cell line:HT-1080	10758-110E2	145.41	28.34
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	297.72	83.10
frontal lobe, adult, pool1	10040-101F4	81.63	108.74
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	194.86	110.19
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	157.45	62.54
gall bladder, adult	10198-103E9	87.16	50.70
gamma delta positive T cells, donor1	11937-126A2	98.24	57.98
gamma delta positive T cells, donor2	11938-126A3	79.93	47.81
gastric adenocarcinoma cell line:MKN1	10614-108G2	103.07	29.15
gastric adenocarcinoma cell line:MKN45	10612-108F9	178.52	58.22
gastric cancer cell line:AZ521	10549-107H9	222.32	141.66
gastric cancer cell line:GSS	10560-108A2	319.41	125.39
gastrointestinal carcinoma cell line:ECC12	10615-108G3	291.28	80.87
giant cell carcinoma cell line:LU65	10487-107B1	183.70	38.67
giant cell carcinoma cell line:Lu99B	10433-106E1	198.46	57.24
glassy cell carcinoma cell line:HOKUG	10688-109F4	251.91	64.35
glioblastoma cell line:A172, tech_rep1	10444-106F3	153.90	76.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	170.07	80.33
glioblastoma cell line:T98G	10485-107A8	94.70	61.37
glioma cell line:GI-1	10413-106B8	111.88	37.49
globus pallidus - adult, donor10196	10175-103C4	153.80	158.17
globus pallidus, adult, donor10252	10161-103A8	158.91	166.47
globus pallidus, adult, donor10258	10367-105F7	108.17	76.68
globus pallidus, newborn, donor10223	10364-105F4	169.47	56.49
granulocyte macrophage progenitor, donor1	12131-128D7	633.81	261.84
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	10.45
granulosa cell tumor cell line:KGN	10624-108H3	131.84	26.24
hIPS +CCl2, biol_rep1	14383-156B9	187.78	87.23
hIPS +CCl2, biol_rep2	14384-156C1	157.76	81.85
hIPS +CCl2, biol_rep3	14385-156C2	215.13	94.04
hIPS, biol_rep1	14380-156B6	250.09	45.99
hIPS, biol_rep2	14381-156B7	157.75	73.39
hIPS, biol_rep3	14382-156B8	129.11	86.07
hairy cell leukemia cell line:Mo	10712-109I1	98.56	42.81
heart - mitral valve, adult	10205-103F7	98.36	76.54
heart - pulmonic valve, adult	10206-103F8	153.22	108.51
heart - tricuspid valve, adult	10207-103F9	456.29	130.72
heart, adult, diseased post-infarction, donor1	10050-101G5	63.05	29.18
heart, adult, diseased, donor1	10051-101G6	56.64	18.74
heart, adult, pool1	10016-101C7	189.73	137.07
heart, fetal, pool1	10046-101G1	170.65	81.63
hepatic mesenchymal tumor cell line:LI90	10778-110G4	138.22	37.33
hepatoblastoma cell line:HuH-6	10633-108I3	871.67	141.51
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	243.97	101.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	223.45	94.43
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	244.04	103.88
hepatoma cell line:Li-7	10484-107A7	334.54	114.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	171.76	75.07
hippocampus - adult, donor10196	10169-103B7	146.68	126.81
hippocampus, adult, donor10252	10153-102I9	114.50	132.66
hippocampus, adult, donor10258	10374-105G5	119.51	67.72
hippocampus, newborn, donor10223	10363-105F3	107.51	59.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	186.15	168.45
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	84.04	84.63
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	99.53	86.32
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	76.69	49.06
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	69.72	66.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	83.13	57.70
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	95.47	63.06
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	71.52	55.37
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	90.50	59.22
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	102.06	66.07
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	99.32	75.54
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	117.15	73.39
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	57.27	57.12
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	76.15	72.71
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	154.48	118.69
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	81.71	56.13
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	74.57	47.97
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	141.43	89.96
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	39.75	44.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	57.29	47.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	57.95	43.85
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	84.43	46.05
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	84.48	54.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	119.27	55.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	85.17	90.89
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	82.45	67.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	160.87	129.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	86.61	65.13
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	70.00	51.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	80.80	60.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	57.92	41.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	60.44	42.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	80.04	54.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	86.92	54.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	101.47	69.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	122.66	64.86
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	95.88	68.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	150.19	128.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	109.27	84.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	81.91	54.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	497.75	312.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	106.56	82.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	68.41	51.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	67.31	45.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	65.12	55.87
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	126.50	78.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	112.67	80.04
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	106.68	59.00
immature langerhans cells, donor1	11904-125F5	315.27	60.29
immature langerhans cells, donor2	11905-125F6	209.12	38.02
insula, adult, pool1	10039-101F3	74.10	91.04
keratoacanthoma cell line:HKA-1	10791-110H8	70.88	17.88
kidney, adult, pool1	10017-101C8	138.28	78.80
kidney, fetal, pool1	10045-101F9	80.36	48.52
large cell lung carcinoma cell line:IA-LM	10509-107D5	365.42	97.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	144.88	18.39
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	235.61	42.94
left atrium, adult, donor1	10079-102A7	51.76	35.96
left ventricle, adult, donor1	10078-102A6	86.47	43.99
leiomyoblastoma cell line:G-402	10721-110A1	194.26	112.45
leiomyoma cell line:10964C	10569-108B2	32.69	13.65
leiomyoma cell line:15242A	10570-108B3	46.74	8.15
leiomyoma cell line:15425	10571-108B4	59.25	16.27
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	50.79
lens epithelial cell line:SRA 01/04	10647-109A8	159.97	41.82
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	402.58	68.47
liposarcoma cell line:KMLS-1	10782-110G8	64.51	20.15
liposarcoma cell line:SW 872	10726-110A6	65.91	25.83
liver, adult, pool1	10018-101C9	216.19	108.42
liver, fetal, pool1	10086-102B5	62.09	17.87
locus coeruleus - adult, donor10196	10182-103D2	168.14	199.63
locus coeruleus, adult, donor10252	10165-103B3	100.95	105.38
locus coeruleus, adult, donor10258	10375-105G6	30.47	45.42
locus coeruleus, newborn, donor10223	10362-105F2	323.88	147.64
lung adenocarcinoma cell line:A549	10499-107C4	200.67	62.42
lung adenocarcinoma cell line:PC-14	10408-106B3	408.82	196.48
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	188.23	65.25
lung, adult, pool1	10019-101D1	88.00	61.07
lung, fetal, donor1	10068-101I5	266.86	162.40
lung, right lower lobe, adult, donor1	10075-102A3	49.95	50.86
lymph node, adult, donor1	10077-102A5	56.33	31.72
lymphangiectasia cell line:DS-1	10727-110A7	135.23	49.31
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	175.23	127.53
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	523.29	152.06
mature adipocyte, donor1	12231-129F8	192.25	161.17
mature adipocyte, donor2	12232-129F9	137.18	127.63
mature adipocyte, donor3	12233-129G1	117.58	108.57
mature adipocyte, donor4	12234-129G2	145.30	118.97
maxillary sinus tumor cell line:HSQ-89	10414-106B9	393.84	263.75
medial frontal gyrus - adult, donor10196	10170-103B8	125.21	138.75
medial frontal gyrus, adult, donor10252	10150-102I6	123.77	139.58
medial frontal gyrus, adult, donor10258	10368-105F8	105.79	91.49
medial frontal gyrus, newborn, donor10223	10352-105E1	310.48	174.01
medial temporal gyrus - adult, donor10196	10183-103D3	136.52	150.02
medial temporal gyrus, adult, donor10252	10156-103A3	150.47	140.92
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	194.55	55.86
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	875.57	516.73
medial temporal gyrus, newborn, donor10223	10353-105E2	137.83	77.89
medulla oblongata - adult, donor10196	10174-103C3	168.09	133.04
medulla oblongata, adult, donor10252	10155-103A2	97.53	116.10
medulla oblongata, adult, pool1	10038-101F2	71.02	95.34
medulla oblongata, newborn, donor10223	10361-105F1	158.66	88.88
medulloblastoma cell line:D283 Med	10838-111E1	364.22	95.87
medulloblastoma cell line:ONS-76	10759-110E3	187.08	61.38
melanoma cell line:COLO 679	10514-107E1	73.17	43.12
melanoma cell line:G-361	10465-106H6	223.41	57.28
meningioma cell line:HKBMM	10691-109F7	82.67	27.50
merkel cell carcinoma cell line:MKL-1	10843-111E6	252.89	125.12
merkel cell carcinoma cell line:MS-1	10844-111E7	76.99	64.55
mesenchymal precursor cell - adipose, donor1	11747-123G1	110.93	27.93
mesenchymal precursor cell - adipose, donor2	11748-123G2	109.80	29.81
mesenchymal precursor cell - adipose, donor3	11749-123G3	104.35	19.46
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	56.47	11.10
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	49.68	21.76
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	51.36	18.05
mesenchymal precursor cell - cardiac, donor1	11752-123G6	60.93	18.36
mesenchymal precursor cell - cardiac, donor2	11753-123G7	60.96	16.45
mesenchymal precursor cell - cardiac, donor3	11754-123G8	84.22	21.62
mesenchymal precursor cell - cardiac, donor4	11755-123G9	87.91	24.58
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	111.53	26.75
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	87.61	16.47
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	87.45	22.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	89.02	26.88
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	64.11	15.11
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	62.19	21.57
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	48.41	13.86
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	50.84	13.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	162.79	44.47
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	78.31	18.08
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	75.54	21.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	68.85	19.88
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	64.39	23.75
mesenchymal stem cell line:Hu5/E18	10568-108B1	99.36	37.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	72.61	20.55
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	60.62	25.07
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	71.20	28.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	69.63	27.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	66.61	29.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	80.21	25.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	71.13	26.33
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	76.92	27.80
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	71.53	27.98
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	63.81	22.76
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	63.93	26.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	121.00	48.40
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	65.45	23.83
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	62.63	25.38
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	69.16	28.78
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	46.48	30.08
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	108.46	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	74.05	29.56
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	61.11	23.28
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	74.63	34.65
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	63.79	14.72
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	76.58	33.04
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	54.57	20.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	62.59	24.84
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	28.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	65.82	19.57
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	67.02	19.50
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	70.31	32.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	64.50	22.76
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	77.37	21.49
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	47.90	23.95
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	82.65	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	52.16	19.97
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	60.38	19.07
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	57.18	17.69
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	73.25	25.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	64.16	25.40
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	88.70	29.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	105.29	30.82
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	87.43	38.55
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	65.31	52.94
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	61.68	51.59
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	61.06	67.42
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	58.84	51.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	37.07	54.51
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	48.15	45.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	81.32	47.94
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	85.86	27.11
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	71.66	47.77
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	58.73	51.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	49.32	41.54
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	47.88	40.75
mesodermal tumor cell line:HIRS-BM	10696-109G3	211.22	121.47
mesothelioma cell line:ACC-MESO-1	10493-107B7	197.97	138.20
mesothelioma cell line:ACC-MESO-4	10494-107B8	218.93	95.68
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	183.76	25.64
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	122.27	30.41
mesothelioma cell line:Mero-25	10850-111F4	203.12	58.10
mesothelioma cell line:Mero-41	10851-111F5	227.12	68.45
mesothelioma cell line:Mero-48a	10852-111F6	97.87	32.99
mesothelioma cell line:Mero-82	10853-111F7	260.18	43.10
mesothelioma cell line:Mero-83	10854-111F8	104.00	19.41
mesothelioma cell line:Mero-84	10855-111F9	127.40	30.59
mesothelioma cell line:Mero-95	10856-111G1	59.42	21.53
mesothelioma cell line:NCI-H2052	10847-111F1	158.69	25.68
mesothelioma cell line:NCI-H226	10846-111E9	262.08	57.19
mesothelioma cell line:NCI-H2452	10848-111F2	190.64	56.37
mesothelioma cell line:NCI-H28	10845-111E8	184.23	76.09
mesothelioma cell line:No36	10857-111G2	176.80	64.59
mesothelioma cell line:ONE58	10858-111G3	166.09	32.79
migratory langerhans cells, donor1	11901-125F2	98.07	57.58
migratory langerhans cells, donor2	11902-125F3	86.34	44.21
migratory langerhans cells, donor3	11903-125F4	107.69	62.82
mixed mullerian tumor cell line:HTMMT	10689-109F5	147.24	83.58
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	81.60	26.07
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	628.42	90.53
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	98.00	46.62
myelodysplastic syndrome cell line:SKM-1	10772-110F7	298.99	125.84
myeloma cell line:PCM6	10474-106I6	171.58	64.64
myxofibrosarcoma cell line:MFH-ino	10600-108E6	389.09	53.77
myxofibrosarcoma cell line:NMFH-1	10684-109E9	142.20	23.93
nasal epithelial cells, donor1, tech_rep1	12226-129F3	119.67	36.10
nasal epithelial cells, donor1, tech_rep2	12226-129F3	120.61	44.12
nasal epithelial cells, donor2	12227-129F4	91.63	23.74
neuroblastoma cell line:CHP-134	10508-107D4	576.99	133.67
neuroblastoma cell line:NB-1	10539-107G8	209.16	128.90
neuroblastoma cell line:NBsusSR	10607-108F4	189.80	73.81
neuroblastoma cell line:NH-12	10555-107I6	237.41	78.83
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	113.16	63.34
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	129.24	108.02
neuroectodermal tumor cell line:TASK1	10774-110F9	109.69	53.13
neuroepithelioma cell line:SK-N-MC	10728-110A8	314.07	148.13
neurofibroma cell line:Hs 53.T	10729-110A9	146.39	42.85
neutrophil PMN, donor1	12133-128D9	357.00	148.75
neutrophil PMN, donor2	12137-128E4	13.28	26.56
neutrophil PMN, donor3	12141-128E8	37.88	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	220.87	129.21
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	91.26	47.23
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	56.75	27.89
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	95.38	45.98
nucleus accumbens, adult, pool1	10037-101F1	75.65	85.58
occipital cortex - adult, donor10196	10172-103C1	203.98	206.04
occipital cortex, adult, donor10252	10163-103B1	150.55	135.52
occipital cortex, newborn, donor10223	10355-105E4	133.93	99.72
occipital lobe, adult, donor1	10076-102A4	64.55	92.36
occipital lobe, fetal, donor1	10073-102A1	85.39	118.00
occipital pole, adult, pool1	10036-101E9	45.18	45.18
olfactory region, adult	10195-103E6	83.30	90.75
optic nerve, donor1	10277-104E7	194.10	212.11
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	175.99	62.42
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	146.45	102.35
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	127.67	49.10
oral squamous cell carcinoma cell line:SAS	10544-107H4	109.27	19.41
osteoclastoma cell line:Hs 706.T	10704-109H2	78.49	25.58
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	1762.16	256.94
osteosarcoma cell line:HS-Os-1	10558-107I9	115.57	89.91
ovary, adult, pool1	10020-101D2	82.11	53.90
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	119.71	28.05
pancreas, adult, donor1	10049-101G4	223.87	50.79
pancreatic carcinoma cell line:NOR-P1	10698-109G5	167.16	61.78
papillary adenocarcinoma cell line:8505C	10437-106E5	160.13	48.89
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	231.48	74.84
paracentral gyrus, adult, pool1	10035-101E8	70.20	87.31
parietal cortex, adult, donor10258	10373-105G4	91.75	63.86
parietal lobe - adult, donor10196	10171-103B9	142.95	129.79
parietal lobe, adult, donor10252	10157-103A4	140.81	106.32
parietal lobe, adult, pool1	10034-101E7	59.39	73.23
parietal lobe, fetal, donor1	10072-101I9	128.99	149.35
parietal lobe, newborn, donor10223	10356-105E5	175.34	103.19
parotid gland, adult	10199-103F1	225.08	83.87
penis, adult	10200-103F2	100.44	59.62
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	277.79	115.65
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	163.03	81.15
pineal gland - adult, donor10196	10179-103C8	213.50	84.50
pineal gland, adult, donor10252	10160-103A7	159.90	137.39
pineal gland, adult, donor10258	10377-105G8	144.23	95.94
pituitary gland - adult, donor10196	10180-103C9	239.80	90.05
pituitary gland, adult, donor10252	10162-103A9	228.80	188.15
pituitary gland, adult, donor10258	10378-105G9	123.43	81.72
placenta, adult, pool1	10021-101D3	124.49	72.03
plasma cell leukemia cell line:ARH-77	10840-111E3	123.95	62.24
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	64.59	32.06
pons, adult, pool1	10033-101E6	70.92	108.70
postcentral gyrus, adult, pool1	10032-101E5	55.18	59.63
promyelocytes/myelocytes PMC, donor1	12132-128D8	665.06	200.77
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	44.06
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	23.47
prostate cancer cell line:DU145	10490-107B4	175.96	54.19
prostate cancer cell line:PC-3	10439-106E7	283.87	66.25
prostate, adult, pool1	10022-101D4	81.08	70.47
putamen, adult, donor10196	10176-103C5	112.60	100.80
putamen, adult, donor10252	10152-102I8	156.86	109.80
putamen, adult, donor10258, tech_rep1	10372-105G3	170.48	42.62
putamen, adult, donor10258, tech_rep2	10372-105G3	68.38	57.50
putamen, newborn, donor10223	10365-105F5	287.12	162.68
rectal cancer cell line:TT1TKB	10469-106I1	407.31	132.67
rectum, fetal, donor1	10067-101I4	186.39	107.11
renal cell carcinoma cell line:OS-RC-2	10411-106B6	183.17	68.69
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	70.83	14.91
retina, adult, pool1	10030-101E3	43.14	44.73
retinoblastoma cell line:Y79	10475-106I7	252.53	89.37
rhabdomyosarcoma cell line:KYM-1	10787-110H4	133.15	67.87
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	551.43	259.55
sacrococcigeal teratoma cell line:HTST	10695-109G2	183.40	57.60
salivary acinar cells, donor1	11771-123I7	133.05	21.85
salivary acinar cells, donor2	11772-123I8	88.40	19.96
salivary acinar cells, donor3	11773-123I9	474.03	72.16
salivary gland, adult, pool1	10093-102C3	207.62	47.47
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	129.17	51.85
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	129.31	45.61
seminal vesicle, adult	10201-103F3	155.02	93.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	101.06	26.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	64.67	17.87
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	171.60	38.13
serous cystadenocarcinoma cell line:HTOA	10693-109F9	75.22	21.09
signet ring carcinoma cell line:Kato III	10436-106E4	184.58	83.67
signet ring carcinoma cell line:NUGC-4	10483-107A6	210.57	33.42
skeletal muscle - soleus muscle, donor1	10282-104F3	938.45	225.57
skeletal muscle, adult, pool1	10023-101D5	346.14	136.61
skeletal muscle, fetal, donor1	10066-101I3	60.30	29.15
skin, adult, donor1	10074-102A2	74.64	47.50
skin, fetal, donor1	10065-101I2	97.21	81.43
small cell cervical cancer cell line:HCSC-1	10800-110I8	65.04	72.37
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	182.82	80.06
small cell lung carcinoma cell line:DMS 144	10841-111E4	91.94	147.84
small cell lung carcinoma cell line:LK-2	10541-107H1	491.35	138.95
small cell lung carcinoma cell line:NCI-H82	10842-111E5	272.64	109.38
small cell lung carcinoma cell line:WA-hT	10562-108A4	236.44	83.90
small intestine, adult, pool1	10024-101D6	140.11	54.94
small intestine, fetal, donor1	10064-101I1	67.81	40.05
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	93.35	44.62
smooth muscle, adult, pool1	10048-101G3	84.26	52.98
somatostatinoma cell line:QGP-1	10781-110G7	712.13	118.47
spinal cord - adult, donor10196	10181-103D1	155.08	200.27
spinal cord, adult, donor10252	10159-103A6	170.32	171.90
spinal cord, adult, donor10258	10369-105F9	167.41	144.59
spinal cord, fetal, donor1	10056-101H2	73.79	84.16
spinal cord, newborn, donor10223	10359-105E8	288.84	160.27
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	165.04	35.40
spleen, adult, pool1	10025-101D7	112.89	71.37
spleen, fetal, pool1	10044-101F8	77.55	46.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	80.84	69.25
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	266.97	104.62
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	94.35	44.38
squamous cell carcinoma cell line:T3M-5	10616-108G4	274.04	46.13
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	539.27	157.13
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	168.59	64.39
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	217.46	60.92
stomach, fetal, donor1	10062-101H8	347.09	92.91
submaxillary gland, adult	10202-103F4	189.70	90.58
substantia nigra - adult, donor10196	10178-103C7	271.37	217.10
substantia nigra, adult, donor10252	10158-103A5	99.70	117.77
substantia nigra, adult, donor10258	10371-105G2	128.80	91.55
substantia nigra, newborn, donor10223	10358-105E7	254.37	107.40
synovial sarcoma cell line:HS-SY-II	10441-106E9	91.71	118.53
temporal lobe, adult, pool1	10031-101E4	41.79	52.30
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	67.67	79.06
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	82.63	95.38
tenocyte, donor1	11763-123H8	78.20	28.28
tenocyte, donor2	11765-123I1	49.21	16.02
tenocyte, donor3	11768-123I4	75.62	18.16
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	162.48	142.09
teratocarcinoma cell line:NCR-G1	10798-110I6	64.74	40.39
teratocarcinoma cell line:PA-1	10807-111A6	120.42	63.85
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	157.03	78.71
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	204.97	128.96
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	318.24	106.12
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	137.12	67.75
testis, adult, pool1	10026-101D8	67.22	71.72
testis, adult, pool2	10096-102C6	76.68	83.45
thalamus - adult, donor10196	10168-103B6	160.08	143.52
thalamus, adult, donor10252	10154-103A1	110.34	139.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	267.89	104.69
thalamus, adult, donor10258, tech_rep2	10370-105G1	28.00	30.47
thalamus, newborn, donor10223	10366-105F6	216.90	86.87
throat, adult	10209-103G2	116.85	62.67
throat, fetal, donor1	10061-101H7	79.53	61.25
thymic carcinoma cell line:Ty-82	10803-111A2	191.18	128.78
thymus, adult, pool1	10027-101D9	89.37	80.33
thymus, fetal, pool1	10043-101F7	94.45	73.46
thyroid carcinoma cell line:KHM-5M	10776-110G2	205.69	38.69
thyroid carcinoma cell line:TCO-1	10783-110G9	200.74	64.40
thyroid, adult, pool1	10028-101E1	92.19	64.85
thyroid, fetal, donor1	10060-101H6	82.26	62.49
tongue epidermis (fungiform papillae), donor1	10288-104F9	455.78	113.95
tongue, adult	10203-103F5	156.06	58.84
tongue, fetal, donor1	10059-101H5	135.57	67.00
tonsil, adult, pool1	10047-101G2	132.63	50.29
trachea, adult, pool1	10029-101E2	149.12	62.33
trachea, fetal, donor1	10058-101H4	93.87	46.93
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	110.89	28.34
transitional-cell carcinoma cell line:5637	10418-106C4	194.02	68.79
transitional-cell carcinoma cell line:JMSU1	10492-107B6	214.82	77.40
tridermal teratoma cell line:HGRT	10694-109G1	445.19	78.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	182.93	42.16
umbilical cord, fetal, donor1	10057-101H3	64.68	39.64
uterus, adult, pool1	10100-102D1	121.83	59.72
uterus, fetal, donor1	10055-101H1	99.83	60.92
vagina, adult	10204-103F6	102.10	66.56
vein, adult	10191-103E2	85.49	41.43
xeroderma pigentosum b cell line:XPL 17	10563-108A5	74.50	37.65